Chemoprevention with a Long Acting Somatostatin Analogue in a Multiple Endocrine Neoplasia Type 1 (MEN1) Knockout Mouse Model Does Delay the Progression of Pancreatic Neuroendocrine Neoplasms (pNENs)

被引：0
|
作者：
Lopez, C. [1 ]
Bartsch, D. K. [1 ]
Albers, M. B. [1 ]
Bollmann, C. [1 ]
Roth, S. [1 ]
Bayer, A. [1 ]
Fendrich, V [1 ]
机构：
[1] Univ Marburg, Dept Visceral Thorac & Vasc Surg, Marburg, Germany
来源：
NEUROENDOCRINOLOGY | 2016年 / 103卷
关键词：
Chemoprevention; Neuroendocrine neoplasms; Somatostatin analogue;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C6
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)
    Caroline L. Lopez
    Barbara Joos
    Detlef K. Bartsch
    Jerena Manoharan
    Max Albers
    Emily P. Slater
    Carmen Bollmann
    Sylvia Roth
    Aninja Bayer
    Volker Fendrich
    World Journal of Surgery, 2019, 43 : 831 - 838
  • [2] Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)
    Lopez, Caroline L.
    Joos, Barbara
    Bartsch, Detlef K.
    Manoharan, Jerena
    Albers, Max
    Slater, Emily P.
    Bollmann, Carmen
    Roth, Sylvia
    Bayer, Aninja
    Fendrich, Volker
    WORLD JOURNAL OF SURGERY, 2019, 43 (03) : 831 - 838
  • [3] Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1
    Marini, Francesca
    Giusti, Francesca
    Tonelli, Francesco
    Brandi, Maria Luisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [4] Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model
    Quinn, Thomas J.
    Yuan, Ziqiang
    Adem, Asha
    Geha, Rula
    Vrikshajanani, Chakravarthy
    Koba, Wade
    Fine, Eugene
    Hughes, David T.
    Schmid, Herbert A.
    Libutti, Steven K.
    SURGERY, 2012, 152 (06) : 1068 - 1076
  • [5] Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model DISCUSSION
    Vriens, Menno
    Quinn, Thomas
    Evans, Douglas
    Libutti, Steven
    Parangi, Sareh
    SURGERY, 2012, 152 (06) : 1076 - 1077
  • [6] Multiple endocrine neoplasia type 1 with MEN1 variant of unknown significance, in a patient after the diagnosed of pancreatic neuroendocrine neoplasia
    Tanaka, Yuko
    Niitani, Takafumi
    Matsumoto, Takatsugu
    Abe, Akihito
    Ishida, Kazuyuki
    Aoki, Taku
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03): : 263 - 267
  • [7] Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)
    Effraimidis, Grigoris
    Knigge, Ulrich
    Rossing, Maria
    Oturai, Peter
    Rasmussen, Ase Krogh
    Feldt-Rasmussen, Ulla
    SEMINARS IN CANCER BIOLOGY, 2022, 79 : 141 - 162
  • [8] Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients
    Faggiano, Antongiulio
    Tavares, Lidice Brandao
    Tauchmanova, Libuse
    Milone, Francesco
    Mansueto, Gelsomina
    Ramundo, Valeria
    De Caro, Maria Laura Del Basso
    Lombardi, Gaetano
    De Rosa, Gaetano
    Colao, Annamaria
    CLINICAL ENDOCRINOLOGY, 2008, 69 (05) : 756 - 762
  • [9] Effect of Treatment with Depot Somatostatin Analogue Octreotide on Primary Hyperparathyroidism (PHP) in Multiple Endocrine Neoplasia Type 1 (MEN1) Patients
    Machold, Claudia
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2009, 2 (01): : 28 - 28
  • [10] In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model
    Cui, Min-Hui
    Branch, Craig A.
    Cahill, Sean M.
    Quinn, Thomas J.
    Adem, Asha
    Libutti, Steven K.
    Yuan, Ziqiang
    MAGNETIC RESONANCE IN MEDICINE, 2015, 74 (05) : 1221 - 1226
12345